Skip to main content
. Author manuscript; available in PMC: 2011 Aug 15.
Published in final edited form as: J Infect Dis. 2010 Aug 15;202(4):576–584. doi: 10.1086/654882

TABLE 1.

Prevalence of anti-HCV in various donor groups and adjusted odds ratio for the association with each variable. Reference categories are indicated by adjusted odds ratio (aOR) = 1.0; significant associations are shown in bold font.

Donor Group N Donors n anti-HCV Positive Prevalence per 105 aOR (95% CI)
Donor Status
First time donor 280,612 631 225 38.3 (29.1-50.4)
Repeat donor 675,294 57 8 1.0 -----
Age
<20 179,427 45 25 0.1 (0.1-0.2)
20-29 158,617 82 52 1.0 ---
30-39 141,220 102 72 2.0 (1.5-2.7)
40-49 199,592 246 123 4.3 (3.3-5.5)
50-59 178,893 191 107 4.7 (3.6-6.2)
60+ 101,526 29 29 1.2 (0.8-1.9)
Sex
Male 467,996 415 89 1.8 (1.6-2.1)
Female 491,255 279 57 1.0 -----
Race/Ethnicity
White 810,716 531 65 1.0 -----
Black 56,467 78 138 1.4 (1.1-1.8)
Hispanic 34,722 24 69 0.7 (0.5-1.1)
Asian 22,351 8 36 0.5 (0.2-0.9)
Education
High School or less 265,874 312 117 8.1 (6.2-10.5)
Some College 281,132 219 78 3.8 (2.9-4.9)
College graduate 327,961 74 23 1.0 -----
Ever Transfused
No 815,780 503 62 1.0 -----
Yes 31,252 54 173 2.1 (1.6-2.8)
Body Mass Index
Underweight/Normal <25 342,961 213 62 1.0 -----
Overweight <=30 314,378 240 76 0.9 (0.7-1.1)
Obese >30 218,965 156 71 0.6 (0.5-0.8)
Blood Center
Wisconsin 122,071 48 39 1.0 -----
California 90,462 78 86 3.6 (2.3-4.9)
Georgia 250,759 234 93 2.8 (2.0-3.9)
Ohio 70,521 34 48 2.2 (1.4-3.3)
MA/VT/NH/ME 303,740 202 67 2.5 (1.8-3.4)
Pennsylvania 121,728 99 81 2.8 (2.0-4.0)